These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28579587)

  • 21. A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant.
    Obata F; Murakami T; Miyagi J; Ueda S; Inagaki T; Minato M; Ono H; Nishimura K; Shibata E; Tamaki M; Yoshimoto S; Kishi F; Kishi S; Matsuura M; Nagai K; Abe H; Doi T
    CEN Case Rep; 2017 May; 6(1):55-60. PubMed ID: 28509128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bloody pleural effusion and ascites associated with Kaposi sarcoma in a kidney transplant patient.
    Moghaddasi S; Nouri-Majelan N; Masoumi Dehshiri R
    Iran J Kidney Dis; 2014 Sep; 8(5):424-6. PubMed ID: 25194411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.
    Leroy V; Dumortier J; Coilly A; Sebagh M; Fougerou-Leurent C; Radenne S; Botta D; Durand F; Silvain C; Lebray P; Houssel-Debry P; Kamar N; D'Alteroche L; Petrov-Sanchez V; Diallo A; Pageaux GP; Duclos-Vallee JC;
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1993-2001.e1-2. PubMed ID: 26044317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryoglobulinemia in a moroccan nephrology department.
    Azizi M; Rafik H; Zajjari Y; Montasser DI; El Kabbaj D
    Saudi J Kidney Dis Transpl; 2019; 30(3):663-669. PubMed ID: 31249231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C-associated cryoglobulinemia presenting with pericardial effusion.
    Safadi R; Ilan Y; Ashur Y; Shouval D
    Am J Gastroenterol; 1997 Apr; 92(4):710-2. PubMed ID: 9128336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sofosbuvir and ledipasvir decreased nephrotic syndrome caused by IgA nephropathy with a membranoproliferative pattern of injury in hepatitis C virus-induced cirrhosis: a case report.
    Zhang X; Zhou J; Li C; Rao J; Li Y; Zhang J; Peng H
    Ann Transl Med; 2022 Apr; 10(8):494. PubMed ID: 35571427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
    Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus-induced glomerular disease and posterior reversible encephalopathy syndrome after liver transplant: Case report and literature review.
    Fabrizi F; Paolucci A; Antonelli B; Cerutti R; Donato FM; Lampertico P; Messa P
    Saudi J Kidney Dis Transpl; 2019; 30(1):239-249. PubMed ID: 30804289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.
    Cacoub P; Vautier M; Desbois AC; Lafuma A; Saadoun D
    Liver Int; 2017 Dec; 37(12):1805-1813. PubMed ID: 28467688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.
    Sogni P; Gilbert C; Lacombe K; Piroth L; Rosenthal E; Miailhes P; Gervais A; Esterle L; Chas J; Poizot-Martin I; Dominguez S; Simon A; Morlat P; Neau D; Zucman D; Bouchaud O; Lascoux-Combe C; Bani-Sadr F; Alric L; Goujard C; Vittecoq D; Billaud E; Aumaître H; Boué F; Valantin MA; Dabis F; Salmon D; Wittkop L
    Clin Infect Dis; 2016 Sep; 63(6):763-770. PubMed ID: 27317796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report.
    Grasso A; De Leo P; Malfatti F; Toscanini F; Anselmo M; Menardo G
    Transplant Proc; 2008 Jun; 40(5):1783-5. PubMed ID: 18589196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.
    Fabrizi F; Fogazzi GB; Cresseri D; Passerini P; Martin P; Donato MF; Rumi MG; Messa P
    Kidney Blood Press Res; 2012; 35(6):687-93. PubMed ID: 23307115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].
    Takahashi A; Shima T; Kinoshita N; Yano K; Ueno T; Nishiwaki M; Yamamoto Y; Oya H; Amano I; Matsumoto J; Mitsumoto Y; Tanaka I; Sakai K; Sawai N; Mizuno C; Mizuno M; Itoh Y; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(2):184-194. PubMed ID: 29459562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
    El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
    Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal.
    Fabrizi F; Pozzi C; Farina M; Dattolo P; Lunghi G; Badalamenti S; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1998 Aug; 13(8):1991-7. PubMed ID: 9719153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
    Rutledge SM; Chung RT; Sise ME
    Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Short-term sustained virological response in a patient with liver cirrhosis, hepatitis C, and declining hepatic spare ability during treatment with direct-acting antivirals].
    Mori H; Takaya H; Namisaki T; Noguchi R; Hanatani J; Kaneko M; Seki K; Okura Y; Kitade M; Mitoro A; Yamao J; Yoshiji H
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(5):476-484. PubMed ID: 29743456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Human Erythropoietin (RHuEpo) and Granular Colony Stimulating Factor (G-CSF) in hepatitis C virus (HCV) related to mixed cryoglobulinaemia associated to membranoproliferative glomerulonephritis type I: a case report description.
    Mauro E; Gattei V; Mazzaro C
    Infez Med; 2014 Dec; 22(4):337-41. PubMed ID: 25551853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.